Abstract | PURPOSE OF REVIEW: RECENT FINDINGS: SUMMARY: The use of aspirin has proven to reduce morbidity and mortality associated with CAD. There is a general consensus on aspirin's effectiveness in secondary prevention of CAD. Therefore, aspirin desensitization is necessary in patients with CAD and histories of hypersensitivity reactions to it. The effectiveness of aspirin desensitization and continuous therapy in patients with NERD has been shown in numerous studies. However, shared selection criteria of candidates for aspirin challenge/desensitization procedures, and simple and homogeneous protocols are necessary. Moreover, preventive safety measures are still needed in order to reduce the potential risks of these procedures.
|
Authors | Gabriele Cortellini, Cristiano Caruso, Antonino Romano |
Journal | Current opinion in allergy and clinical immunology
(Curr Opin Allergy Clin Immunol)
Vol. 17
Issue 4
Pg. 247-254
(Aug 2017)
ISSN: 1473-6322 [Electronic] United States |
PMID | 28590311
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Aspirin
(adverse effects, therapeutic use)
- Asthma, Aspirin-Induced
(therapy)
- Coronary Artery Disease
(drug therapy)
- Desensitization, Immunologic
(methods)
- Humans
- Rhinitis, Allergic
(chemically induced, therapy)
|